文献速递冠心病外科

非体外循环冠脉搭桥术前后血小板药物反应性检测

Platelet drug response assay in patients undergoing off-pump coronary artery bypass grafting.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

该回顾性观察研究纳入2021年12月至2023年12月在本机构接受单纯非体外循环冠脉搭桥术(OPCAB)的患者,术前术后用浊度全血法检测阿司匹林反应单位(ARU,阈值550)和P2Y12反应单位(PRU,阈值208)。结果显示术后平均ARU升高,氯吡格雷应答者比例降低,而阿司匹林应答者比例及平均PRU无显著变化。

要点

  • OPCAB术后早期平均ARU升高,但阿司匹林应答者比例无显著变化。
  • OPCAB术后早期氯吡格雷应答者比例显著降低,平均PRU无显著变化。
  • 血小板药物反应性检测或可识别术后抗血小板治疗反应变化。

核心结论

  • OPCAB术后早期绝对ARU值升高且氯吡格雷应答者比例降低,而阿司匹林应答者比例和绝对PRU值无统计学显著变化。

研究设计与样本

  • 回顾性观察研究,纳入2021年12月至2023年12月在本机构接受单纯OPCAB的患者。
  • 术前术后分别对255例和219例患者进行阿司匹林和氯吡格雷的血小板药物反应性检测(PDRA)。
  • 采用浊度全血法检测ARU(应答阈值550)和PRU(阈值208)。

主要发现

  • 术后平均ARU高于术前[474.8 ARU(SD 71.9)vs 441.0 ARU(SD 72.4),P < 0.001]。
  • 阿司匹林应答者比例术前术后分别为85.9%和88.2%,差异无统计学意义(P = 0.50)。
  • 氯吡格雷应答者比例术后显著低于术前(58.9% vs 47.9%,P = 0.019)。
  • 氯吡格雷对血小板功能抑制的比值及平均PRU均无显著变化。

关键数值与推荐

  • 阿司匹林反应性阈值:ARU = 550。
  • 氯吡格雷反应性阈值:PRU = 208。

临床怎么用

  • OPCAB术后早期应关注氯吡格雷应答性降低及ARU升高,必要时进行血小板功能检测。
  • 阿司匹林应答性在术后早期相对稳定,但绝对ARU值升高可能提示需关注个体反应。

局限性

  • 回顾性观察研究,可能存在选择偏倚和混杂因素。
  • 单中心研究,结果外推需谨慎。
  • 未报告临床结局与血小板反应性关系的详细分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We observed antiplatelet drug response before and after off-pump coronary artery bypass grafting (OPCAB) and elucidated the clinical usefulness of the platelet drug response assay (PDRA). METHODS: This retrospective observational study was conducted by including patients who underwent isolated OPCAB at our institution between December 2021 and December 2023. PDRA was performed using a turbidimetric whole-blood assay according to measure aspirin reaction unit (ARU, threshold value for responsiveness = 550) and P2Y12 reaction unit (PRU, threshold = 208). The primary end-point of this study was the change in PDRA values for aspirin and clopidogrel before and after OPCAB. The secondary end-point was early clinical outcomes and perioperative bleeding according to preoperative aspirin responsiveness. RESULTS: PDRAs were performed before and after surgery for aspirin and clopidogrel in 255 and 219 patients, respectively. The mean ARU was higher in the postoperative period than in the preoperative period [474.8 ARU (SD 71.9) vs 441.0 ARU (SD 72.4), P < 0.001], although the proportions of aspirin responders were not significant (85.9% vs 88.2%, P = 0.50). No significant change was observed in the ratio of the platelet function suppression by clopidogrel or in the mean PRU; however, the proportion of clopidogrel responders was significantly lower in the postoperative period (58.9% vs 47.9%, P = 0.019). CONCLUSIONS: The absolute ARU value increases and the proportion of clopidogrel responders decreases in the early postoperative period after OPCAB. By contrast, changes in the proportion of aspirin responders and the absolute PRU value are not statistically significant.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Kim CH, Kang Y, Kim JS, et al. Platelet drug response assay in patients undergoing off-pump coronary artery bypass grafting. Eur J Cardiothorac Surg. 2025. PMID: 40468590. doi:10.1093/ejcts/ezaf183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。